Rabbit Polyclonal CD200 / OX2 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 11 publications. Immunogen corresponding to Synthetic Peptide within Human CD200 aa 1-100 conjugated to Keyhole Limpet Haemocyanin.
View Alternative Names
CD200, MOX1, MOX2, My033, OX-2 membrane glycoprotein
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD200 / OX2 antibody (AB203887)
Immunohistochemistry analysis of Formalin-fixed, paraffin-embedded Human lung carcinoma tissue labeling CD200 / OX2 with ab203887 at 1/200 dilution.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD200 / OX2 antibody (AB203887)
Immunohistochemistry analysis of formalin-fixed, paraffin-embedded Human colon carcinoma tissue labeling CD200 / OX2 with ab203887 at 1/200 dilution.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD200 regulates the immune system by inhibiting inflammatory responses and maintaining immune homeostasis. It does not act as part of a significant multi-protein complex but directly interacts with CD200R. This interaction promotes an anti-inflammatory state and is important in preventing autoimmune diseases and excessive tissue damage. The expression of CD200 is also an indicator of immune tolerance in various tissues.
Pathways
CD200 is involved in immune regulatory pathways. It plays a pivotal role in the suppression of immune responses through the CD200-CD200R signaling pathway. This pathway is vital for dampening inflammatory processes related to autoimmune reactions and is consequently linked to the maintenance of tissue homeostasis. Proteins related to CD200 through these pathways include CD200R and other molecules involved in immune checkpoint pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Cancer immunology, immunotherapy : CII 73:96 PubMed38619621
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 27: PubMed36484353
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cutaneous pathology 49:1044-1050 PubMed36445269
2022
Applications
Unspecified application
Species
Unspecified reactive species
American journal of translational research 13:2365-2378 PubMed34017395
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:648578 PubMed33693006
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuroinflammation 17:247 PubMed32829711
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of dermatology 47:1317-1321 PubMed32794263
2020
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 10:6740 PubMed32317718
2020
Applications
Unspecified application
Species
Unspecified reactive species
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 68:945-955 PubMed31444514
2019
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cellular neuroscience 12:507 PubMed30631265
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com